Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)

Clinical trial NCT02762383 · TERMINATED

Trial details

NCT number: NCT02762383
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV/HCV Coinfection

Start date: 2005-03-01
Primary completion: 2009-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.